Aubrey Capital Management »

BioMarin Pharmaceutical shares owned by Aubrey Capital Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Aubrey Capital Management from 13F filings

Historical chart of Aubrey Capital Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Aubrey Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Aubrey Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $546k 10k 54.04

More positions owned by Aubrey Capital Management

Sea Ltd- Adr (SE)
Futu Hldgs (FUTU)
Grab Holdings Limited Class A Ord (GRAB)
Embraer S A (ERJ)
Latam Airlines Group Sa (LTM)
Didi Global (DIDIY)
Coupang (CPNG)
ICICI Bank (IBN)
MercadoLibre (MELI)
Trip Com Intl Ltd Sponsored Ad (TCOM)
Kanzhun (BZ)
Alibaba Group Holding (BABA)
InterDigital (IDCC)
Comfort Systems USA (FIX)
Broadcom (AVGO)

View all positions for Aubrey Capital Management

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
Morgan Stanley
Goldman Sachs Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust

View all funds holding BioMarin Pharmaceutical